Literature DB >> 5960730

Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices.

A S Michaels.   

Abstract

Mesh：

Substances：

Year:  1966        PMID： 5960730

Source DB:  PubMed          Journal:  Trans Am Soc Artif Intern Organs        ISSN： 0066-0078


× No keyword cloud information.
  15 in total

1.  Solute-removal enhancement caused by local convective flow in a hemodialyzer.

Authors:  Toshiyuki Kanamori; Kensaku Mizoguchi
Journal:  J Artif Organs       Date:  2012-04-05       Impact factor: 1.731

2.  Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study.

Authors:  Timothy W Meyer; Tammy L Sirich; Kara D Fong; Natalie S Plummer; Tariq Shafi; Seungyoung Hwang; Tanushree Banerjee; Yunnuo Zhu; Neil R Powe; Xin Hai; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2016-03-29       Impact factor: 10.121

3.  Simulation-based sodium thiosulfate dosing strategies for the treatment of calciphylaxis.

Authors:  Rajendra Pratap Singh; Hartmut Derendorf; Edward A Ross
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

4.  Theoretical assessment of the effect of flow maldistributions on the mass transfer efficiency of artificial organs.

Authors:  C Vander Velde; E F Leonard
Journal:  Med Biol Eng Comput       Date:  1985-05       Impact factor: 2.602

5.  Dialysate flow rate and delivered Kt/Vurea for dialyzers with enhanced dialysate flow distribution.

Authors:  Richard A Ward; John W Idoux; Hiba Hamdan; Rosemary Ouseph; Thomas A Depner; Thomas A Golper
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-28       Impact factor: 8.237

6.  Administration of aminoglycosides to hemodialysis patients immediately before dialysis: a new dosing modality.

Authors:  H Matsuo; J Hayashi; K Ono; K Andoh; Y Andoh; Y Sano; K Saruki; J Tanaka; M Yamashita; K Nakamura; K Kubo
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

7.  The pharmacokinetics of metformin in patients receiving intermittent haemodialysis.

Authors:  Klarissa A Sinnappah; Isabelle H S Kuan; Tilenka R J Thynne; Matthew P Doogue; Daniel F B Wright
Journal:  Br J Clin Pharmacol       Date:  2020-02-25       Impact factor: 4.335

8.  Pharmacometric characterization of dabigatran hemodialysis.

Authors:  Karl-Heinz Liesenfeld; Alexander Staab; Sebastian Härtter; Stephan Formella; Andreas Clemens; Thorsten Lehr
Journal:  Clin Pharmacokinet       Date:  2013-06       Impact factor: 6.447

9.  Drug dosage in end-stage renal disease (ESRD) patients undergoing haemodialysis. A predictive study based on a microcomputer program.

Authors:  M V Mac-Kay; J Sanchez Burson; J Martinez-Lanao; A Dominguez-Gil
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

10.  A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis.

Authors:  Daniel Fb Wright; Matthew P Doogue; Murray L Barclay; Peter T Chapman; Nicholas B Cross; John H Irvine; Lisa K Stamp
Journal:  Eur J Clin Pharmacol       Date:  2016-09-28       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.